Commonly Observed Adverse Reactions in Controlled Clinical Trials of
Sustained-Release Bupropion Hydrochloride
300 mg/day of bupropion HCl sustained-release:
anorexia, dry mouth, rash, sweating, tinnitus, and tremor.
400 mg/day of bupropion HCl sustained-release:
abdominal pain, agitation, anxiety, dizziness, dry mouth, insomnia, myalgia, nausea, palpitation, pharyngitis,
sweating, tinnitus, and urinary frequecy.
llAdverse reactions that occurred in at least 5% of patients treated with bupropion HCl sustained-release (300 mg and 400 mg per day) and at a rate at least twice the placebo rate are listed.